These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice. Eyer L; Nougairède A; Uhlířová M; Driouich JS; Zouharová D; Valdés JJ; Haviernik J; Gould EA; De Clercq E; de Lamballerie X; Ruzek D J Virol; 2019 Aug; 93(16):. PubMed ID: 31142664 [TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses. Eyer L; Zouharová D; Širmarová J; Fojtíková M; Štefánik M; Haviernik J; Nencka R; de Clercq E; Růžek D Antiviral Res; 2017 Jun; 142():63-67. PubMed ID: 28336346 [TBL] [Abstract][Full Text] [Related]
9. Compounds based on 5-(perylen-3-ylethynyl)uracil scaffold: High activity against tick-borne encephalitis virus and non-specific activity against enterovirus A. Chistov AA; Orlov AA; Streshnev PP; Slesarchuk NA; Aparin IO; Rathi B; Brylev VA; Kutyakov SV; Mikhura IV; Ustinov AV; Westman G; Palyulin VA; Jain N; Osolodkin DI; Kozlovskaya LI; Korshun VA Eur J Med Chem; 2019 Jun; 171():93-103. PubMed ID: 30909022 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of antivirals against tick-borne encephalitis virus in organotypic brain slices of rat cerebellum. Lenz N; Engler O; Grandgirard D; Leib SL; Ackermann-Gäumann R PLoS One; 2018; 13(10):e0205294. PubMed ID: 30300398 [TBL] [Abstract][Full Text] [Related]